• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗重度抑郁症的新型艾司西酞普兰衍生物的3D-QSAR设计

3D-QSAR design of new escitalopram derivatives for the treatment of major depressive disorders.

作者信息

Avram Speranta, Buiu Catalin, Duda-Seiman Daniel M, Duda-Seiman Corina, Mihailescu Dan

机构信息

Department of Anatomy, Animal Physiology and Biophysics, Faculty of Biology, University of Bucharest, 91-95, Splaiul Independentei, RO-76201, Bucharest, Romania.

出版信息

Sci Pharm. 2010 Apr-Jun;78(2):233-48. doi: 10.3797/scipharm.0912-22. Epub 2010 May 5.

DOI:10.3797/scipharm.0912-22
PMID:21179345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3002802/
Abstract

Antidepressants are psychiatric agents used for the treatment of different types of depression being at present amongst the most commonly prescribed drug, while their effectiveness and adverse effects are the subject of many studies and competing claims. Having studied five QSAR models predicting the biological activities of 18 antidepressants, already approved for clinical treatment, in interaction with the serotonin transporter (SERT), we attempted to establish the membrane ionsâ contributions (sodium, potassium, chlorine and calcium) supplied by donor/acceptor hydrogen bond character and electrostatic field to the antidepressant activity. Significant cross-validated correlation q(2) (0.5â0.6) and the fitted correlation r(2) (0.7â0.82) coefficients were obtained indicating that the models can predict the antidepressant activity of compounds. Moreover, considering the contribution of membrane ions (sodium, potassium and calcium) and hydrogen bond donor character, we have proposed a library of 24 new escitalopram structures, some of them probably with significantly improved antidepressant activity in comparison with the parent compound.

摘要

抗抑郁药是用于治疗不同类型抑郁症的精神药物,目前是最常处方的药物之一,而它们的有效性和副作用是许多研究和相互矛盾的说法的主题。在研究了五个预测已批准用于临床治疗的18种抗抑郁药与5-羟色胺转运体(SERT)相互作用的生物活性的定量构效关系(QSAR)模型后,我们试图确定由供体/受体氢键特征和静电场提供的膜离子(钠、钾、氯和钙)对抗抑郁活性的贡献。获得了显著的交叉验证相关系数q(2)(0.5至0.6)和拟合相关系数r(2)(0.7至0.82),表明这些模型可以预测化合物的抗抑郁活性。此外,考虑到膜离子(钠、钾和钙)的贡献以及氢键供体特征,我们提出了一个包含24种新艾司西酞普兰结构的库,其中一些与母体化合物相比可能具有显著提高的抗抑郁活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7582/3002802/c208a1313e06/scipharm.2010.78.233f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7582/3002802/c208a1313e06/scipharm.2010.78.233f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7582/3002802/c208a1313e06/scipharm.2010.78.233f1.jpg

相似文献

1
3D-QSAR design of new escitalopram derivatives for the treatment of major depressive disorders.用于治疗重度抑郁症的新型艾司西酞普兰衍生物的3D-QSAR设计
Sci Pharm. 2010 Apr-Jun;78(2):233-48. doi: 10.3797/scipharm.0912-22. Epub 2010 May 5.
2
3D-QSAR study indicates an enhancing effect of membrane ions on psychiatric drugs targeting serotonin receptor 5-HT1A.三维定量构效关系研究表明,膜离子对靶向5-羟色胺受体5-HT1A的精神药物具有增强作用。
Mol Biosyst. 2012 Apr;8(5):1418-25. doi: 10.1039/c2mb00005a. Epub 2012 Feb 28.
3
Evaluation of the pharmacological descriptors related to the induction of antidepressant activity and its prediction by QSAR/QRAR methods.评价与抗抑郁活性诱导相关的药理学描述符及其通过定量构效关系/定量构效预测方法的预测。
Mini Rev Med Chem. 2012 Jun;12(6):467-76. doi: 10.2174/138955712800493834.
4
3D-ALMOND-QSAR Models to Predict the Antidepressant Effect of Some Natural Compounds.用于预测某些天然化合物抗抑郁作用的3D-杏仁QSAR模型。
Pharmaceutics. 2021 Sep 10;13(9):1449. doi: 10.3390/pharmaceutics13091449.
5
Modification of polychlorinated phenols and evaluation of their toxicity, biodegradation and bioconcentration using three-dimensional quantitative structure-activity relationship models.多氯酚的改性及其毒性、生物降解和生物富集的评估——使用三维定量构效关系模型
J Mol Graph Model. 2017 Jan;71:1-12. doi: 10.1016/j.jmgm.2016.10.012. Epub 2016 Oct 21.
6
More effective antimicrobial mastoparan derivatives, generated by 3D-QSAR-Almond and computational mutagenesis.
Mol Biosyst. 2012 Feb;8(2):587-94. doi: 10.1039/c1mb05297g. Epub 2011 Nov 15.
7
Pharmacophore modeling, virtual screening and 3D-QSAR studies of 5-tetrahydroquinolinylidine aminoguanidine derivatives as sodium hydrogen exchanger inhibitors.基于药效团模型的 5-四氢喹啉亚胺基胍类化合物设计、虚拟筛选及 3D-QSAR 研究
Bioorg Med Chem Lett. 2012 Jun 1;22(11):3758-65. doi: 10.1016/j.bmcl.2012.04.012. Epub 2012 Apr 13.
8
An activity model for novel antidepressants that interact with the serotonin transporter (SERT).一种与5-羟色胺转运体(SERT)相互作用的新型抗抑郁药的活性模型。
Cent Nerv Syst Agents Med Chem. 2011 Sep 1;11(3):228-37. doi: 10.2174/187152411798047762.
9
Three-dimensional quantitative structure-activity relationship (3D QSAR) and pharmacophore elucidation of tetrahydropyran derivatives as serotonin and norepinephrine transporter inhibitors.四氢吡喃衍生物作为5-羟色胺和去甲肾上腺素转运体抑制剂的三维定量构效关系(3D QSAR)及药效团阐释
J Comput Aided Mol Des. 2008 Jan;22(1):1-17. doi: 10.1007/s10822-007-9146-7. Epub 2007 Dec 4.
10
Definition of an uptake pharmacophore of the serotonin transporter through 3D-QSAR analysis.通过三维定量构效关系分析确定5-羟色胺转运体摄取药效团的定义。
Curr Med Chem. 2005;12(20):2393-410. doi: 10.2174/0929867054864813.

引用本文的文献

1
Machine Learning Tool for New Selective Serotonin and Serotonin-Norepinephrine Reuptake Inhibitors.新型选择性5-羟色胺及5-羟色胺-去甲肾上腺素再摄取抑制剂的机器学习工具
Molecules. 2025 Jan 31;30(3):637. doi: 10.3390/molecules30030637.
2
3D-ALMOND-QSAR Models to Predict the Antidepressant Effect of Some Natural Compounds.用于预测某些天然化合物抗抑郁作用的3D-杏仁QSAR模型。
Pharmaceutics. 2021 Sep 10;13(9):1449. doi: 10.3390/pharmaceutics13091449.
3
Current Treatment Strategies and Nanoparticle-Mediated Drug Delivery Systems for Pulmonary Arterial Hypertension.

本文引用的文献

1
Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.魁北克社区居住老年人群中抗抑郁治疗不持续的经济影响。
J Affect Disord. 2009 May;115(1-2):160-6. doi: 10.1016/j.jad.2008.07.004. Epub 2008 Aug 9.
2
Two-dimensional QSAR studies on arylpiperazines as high-affinity 5-HT(1A) receptor ligands.作为高亲和力5-HT(1A)受体配体的芳基哌嗪的二维定量构效关系研究。
Med Chem. 2008 Jul;4(4):328-35. doi: 10.2174/157340608784872325.
3
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines.
肺动脉高压的当前治疗策略和纳米颗粒介导的药物传递系统。
Int J Mol Sci. 2019 Nov 23;20(23):5885. doi: 10.3390/ijms20235885.
4
Preparation and Characterization of Whey Protein Isolate-DIM Nanoparticles.乳清分离蛋白-DIM 纳米粒子的制备与表征。
Int J Mol Sci. 2019 Aug 12;20(16):3917. doi: 10.3390/ijms20163917.
5
Prevention of Deficit in Neuropsychiatric Disorders through Monitoring of Arsenic and Its Derivatives as Well as Through Bioinformatics and Cheminformatics.通过监测砷及其衍生物以及生物信息学和化学信息学来预防神经精神障碍。
Int J Mol Sci. 2019 Apr 12;20(8):1804. doi: 10.3390/ijms20081804.
基于证据的抗抑郁药治疗抑郁症指南:2000年英国精神药理学会指南修订版
J Psychopharmacol. 2008 Jun;22(4):343-96. doi: 10.1177/0269881107088441. Epub 2008 Apr 15.
4
QSAR study on dual 5-HT1A and 5-HT1B antagonists: an insight into the structural requirement for antidepressant activity.5-羟色胺1A和5-羟色胺1B双重拮抗剂的定量构效关系研究:深入了解抗抑郁活性的结构要求
Arch Pharm (Weinheim). 2008 May;341(5):314-22. doi: 10.1002/ardp.200700224.
5
Major depressive disorder.重度抑郁症
N Engl J Med. 2008 Jan 3;358(1):55-68. doi: 10.1056/NEJMra073096.
6
A chemometric study of the 5-HT(1A) receptor affinities presented by arylpiperazine compounds.芳基哌嗪化合物对5-HT(1A)受体亲和力的化学计量学研究。
Eur J Med Chem. 2008 Feb;43(2):364-72. doi: 10.1016/j.ejmech.2007.03.036. Epub 2007 Apr 24.
7
Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase A inhibitors.1,3,5-三取代-4,5-二氢-(1H)-吡唑衍生物作为强效且高度选择性单胺氧化酶A抑制剂的合成、生物学评价及三维定量构效关系研究
Curr Med Chem. 2006;13(12):1411-28. doi: 10.2174/092986706776872907.
8
The medical management of depression.抑郁症的医学治疗
N Engl J Med. 2005 Oct 27;353(17):1819-34. doi: 10.1056/NEJMra050730.
9
Cost of disorders of the brain in Europe.欧洲脑部疾病的成本。
Eur J Neurol. 2005 Jun;12 Suppl 1:1-27. doi: 10.1111/j.1468-1331.2005.01202.x.
10
A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.一项比较三环类抗抑郁药、选择性5-羟色胺再摄取抑制剂和洛非帕明成本效益的随机对照试验。
Health Technol Assess. 2005 May;9(16):1-134, iii. doi: 10.3310/hta9160.